mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.004 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.005 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.13 |
0.005 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
0.006 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |